Dong Jie, Liu Zeye, Dong Jing, Fang Fang, Zhang Fengwen, Pan Xiangbin
Department of Structural Heart Disease, National Center for Cardiovascular Disease, China & Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Med Rev (2021). 2025 Jan 14;5(2):174-176. doi: 10.1515/mr-2024-0101. eCollection 2025 Apr.
The advancement of catheter-based interventional techniques represents a significant evolution in cardiovascular medicine. However, traditional methods that rely on fluoroscopic guidance present considerable limitations including radiation exposure and contrast agent-related risks and the heavy load-caused lead suits. In response, zero or low X-ray emerge, including percutaneous and non-fluoroscopical (PAN) procedure coming as a transformative solution, particularly in treating congenital heart disease, valvular disease, and arrhythmias. These methods minimize the risk of iatrogenic injuries associated with radiative procedures. Innovative PAN procedures and methodologies have been developed to enhance imaging, transcatheter interventions, safety, and accuracy, overcoming previous limitations. By eliminating radiation and expanding accessibility, PAN procedures offer a safe, effective, and economically viable alternative to traditional methods, ushering in a new era of minimally invasive cardiovascular treatment.
基于导管的介入技术的进步代表了心血管医学的重大发展。然而，依赖荧光透视引导的传统方法存在相当大的局限性，包括辐射暴露、与造影剂相关的风险以及沉重负荷导致的铅衣。作为回应，零射线或低射线技术出现了，包括经皮非荧光透视（PAN）手术，它成为一种变革性的解决方案，特别是在治疗先天性心脏病、瓣膜疾病和心律失常方面。这些方法将与放射手术相关的医源性损伤风险降至最低。已经开发出创新的PAN手术和方法来增强成像、经导管干预、安全性和准确性，克服了以前的局限性。通过消除辐射并扩大可及性，PAN手术为传统方法提供了一种安全、有效且经济可行的替代方案，开创了微创心血管治疗的新时代。
